Jane J. Zara

Array ( [id] => 8421547 [patent_doc_number] => 08278035 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-02 [patent_title] => 'Method and substances for isolating miRNAs' [patent_app_type] => utility [patent_app_number] => 10/593383 [patent_app_country] => US [patent_app_date] => 2006-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 20291 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 455 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10593383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 341748 [patent_doc_number] => 07501506 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-10 [patent_title] => 'Pentopyranosyl nucleic acid conjugates' [patent_app_type] => utility [patent_app_number] => 11/499543 [patent_app_country] => US [patent_app_date] => 2006-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18402 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/501/07501506.pdf [firstpage_image] =>[orig_patent_app_number] => 11499543 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4711085 [patent_doc_number] => 20080299611 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'Host Cell Protein Knock-Out Cells for Production of Therapeutic Proteins' [patent_app_type] => utility [patent_app_number] => 11/995109 [patent_app_country] => US [patent_app_date] => 2006-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11619 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11995109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5374835 [patent_doc_number] => 20090312396 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'METHODS FOR CANCER TREATMENT USING TAK1 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/373001 [patent_app_country] => US [patent_app_date] => 2006-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10964 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20090312396.pdf [firstpage_image] =>[orig_patent_app_number] => 12373001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4853142 [patent_doc_number] => 20080318885 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'Method for Modulating Responsiveness to Steroids' [patent_app_type] => utility [patent_app_number] => 11/917748 [patent_app_country] => US [patent_app_date] => 2006-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 12784 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20080318885.pdf [firstpage_image] =>[orig_patent_app_number] => 11917748 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5080257 [patent_doc_number] => 20070123481 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-31 [patent_title] => 'Antisense IAP oligonucleotides and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/477474 [patent_app_country] => US [patent_app_date] => 2006-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 67 [patent_figures_cnt] => 67 [patent_no_of_words] => 16918 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20070123481.pdf [firstpage_image] =>[orig_patent_app_number] => 11477474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8375314 [patent_doc_number] => 08258107 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-04 [patent_title] => 'Immunostimulatory method' [patent_app_type] => utility [patent_app_number] => 11/917482 [patent_app_country] => US [patent_app_date] => 2006-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12090 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11917482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4989345 [patent_doc_number] => 20070155686 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-05 [patent_title] => 'RNAi modulation of HIF-1 and therapeutic uses thereof' [patent_app_type] => utility [patent_app_number] => 11/477028 [patent_app_country] => US [patent_app_date] => 2006-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16418 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20070155686.pdf [firstpage_image] =>[orig_patent_app_number] => 11477028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6603159 [patent_doc_number] => 20100292454 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'NEURONAL REGENERATION PROMOTING AGENT' [patent_app_type] => utility [patent_app_number] => 11/993575 [patent_app_country] => US [patent_app_date] => 2006-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5540 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20100292454.pdf [firstpage_image] =>[orig_patent_app_number] => 11993575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5436206 [patent_doc_number] => 20090170793 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'ARTIFICIAL RIBOSWITCH FOR CONTROLLING PRE-MRNA SPLICING' [patent_app_type] => utility [patent_app_number] => 11/446527 [patent_app_country] => US [patent_app_date] => 2006-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 22832 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170793.pdf [firstpage_image] =>[orig_patent_app_number] => 11446527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5304259 [patent_doc_number] => 20090298911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'SIRNA HAVING ANTIVIRAL ACTIVITY AGAINST NONPOLIO ENTEROVIRUS' [patent_app_type] => utility [patent_app_number] => 11/916131 [patent_app_country] => US [patent_app_date] => 2006-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3245 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20090298911.pdf [firstpage_image] =>[orig_patent_app_number] => 11916131 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7693963 [patent_doc_number] => 20070015723 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-18 [patent_title] => 'Antiviral oligonucleotides having a conserved G4 core sequence' [patent_app_type] => utility [patent_app_number] => 11/436901 [patent_app_country] => US [patent_app_date] => 2006-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 19359 [patent_no_of_claims] => 84 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20070015723.pdf [firstpage_image] =>[orig_patent_app_number] => 11436901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5079597 [patent_doc_number] => 20070122821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-31 [patent_title] => 'Antisense composition and method for treating muscle atrophy' [patent_app_type] => utility [patent_app_number] => 11/433724 [patent_app_country] => US [patent_app_date] => 2006-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8440 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20070122821.pdf [firstpage_image] =>[orig_patent_app_number] => 11433724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5149482 [patent_doc_number] => 20070049542 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'Antisense antibacterial method and compound' [patent_app_type] => utility [patent_app_number] => 11/432216 [patent_app_country] => US [patent_app_date] => 2006-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 19103 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20070049542.pdf [firstpage_image] =>[orig_patent_app_number] => 11432216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5835368 [patent_doc_number] => 20060247199 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Methods and products for manipulating uncoupling protein expression' [patent_app_type] => utility [patent_app_number] => 11/409446 [patent_app_country] => US [patent_app_date] => 2006-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34431 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20060247199.pdf [firstpage_image] =>[orig_patent_app_number] => 11409446 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4994185 [patent_doc_number] => 20070009530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-11 [patent_title] => 'Methods and compositions for inhibiting tumorigenesis' [patent_app_type] => utility [patent_app_number] => 11/407702 [patent_app_country] => US [patent_app_date] => 2006-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 63894 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20070009530.pdf [firstpage_image] =>[orig_patent_app_number] => 11407702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5688952 [patent_doc_number] => 20060287267 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'RNA interference mediated inhibition of respiratory syncytial virus (RSV) expression using short interfering nucleic acid (siNA)' [patent_app_type] => utility [patent_app_number] => 11/395833 [patent_app_country] => US [patent_app_date] => 2006-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 111552 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20060287267.pdf [firstpage_image] =>[orig_patent_app_number] => 11395833 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5679676 [patent_doc_number] => 20060185032 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Cytochrome P450 reductases from poppy plants' [patent_app_type] => utility [patent_app_number] => 11/395689 [patent_app_country] => US [patent_app_date] => 2006-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 9377 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20060185032.pdf [firstpage_image] =>[orig_patent_app_number] => 11395689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4960487 [patent_doc_number] => 20080274912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'Single Walled Carbon Nanotubes Functionally Adsorbed to Biopolymers for Use as Chemical Sensors' [patent_app_type] => utility [patent_app_number] => 11/910070 [patent_app_country] => US [patent_app_date] => 2006-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6515 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20080274912.pdf [firstpage_image] =>[orig_patent_app_number] => 11910070 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5875226 [patent_doc_number] => 20060166924 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Gene therapeutics' [patent_app_type] => utility [patent_app_number] => 11/390345 [patent_app_country] => US [patent_app_date] => 2006-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7593 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20060166924.pdf [firstpage_image] =>[orig_patent_app_number] => 11390345 [rel_patent_id] =>[rel_patent_doc_number] =>)